Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Gross Profit of $40.30 million for fiscal year 2025.
LIFECORE BIOMEDICAL, INC. \DE\ Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $40.30M | -3.7% |
| 2024 | $41.85M | +49.5% |
| 2023 | $27.98M | -28.4% |
| 2022 | $39.07M | +0.3% |
| 2021 | $38.94M | -1.1% |
| 2020 | $39.39M | -51.4% |
| 2019 | $81.00M | +3.4% |
| 2018 | $78.34M | -1.1% |
| 2017 | $79.21M | +18.6% |
| 2016 | $66.78M | +2.1% |
| 2015 | $65.41M | +4.5% |
| 2014 | $62.56M | -0.3% |
| 2013 | $62.76M | +20.4% |
| 2012 | $52.14M | +11.7% |
| 2011 | $46.70M | +38.3% |
| 2010 | $33.77M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.79M | — | -20.9% |
| February 28, 2025 | $9.85M | -17.2% | -11.2% |
| November 30, 2024 | $11.08M | +11.3% | +105.8% |
| August 31, 2024 | $5.39M | +97.5% | -54.7% |
| February 29, 2024 | $11.89M | +39.1% | +19.5% |
| November 30, 2023 | $9.96M | +75.3% | +265.0% |
| August 31, 2023 | $2.73M | -54.4% | -68.1% |
| February 28, 2023 | $8.55M | -33.6% | +50.5% |
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -3.7% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2025 period, LIFECORE BIOMEDICAL, INC. \DE\’s gross profit has grown by 19.3% (from $33.77 million to $40.30 million).
- The most recent figure is from LIFECORE BIOMEDICAL, INC. \DE\’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: